These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9660844)

  • 41. Ciclesonide and budesonide suspensions for nebulization delivery: An in vivo inhalation biopharmaceutics investigation.
    Fu TT; Zhao Y; Yang FF; Wen H; Liu CY; Liao YH
    Int J Pharm; 2018 Oct; 549(1-2):21-30. PubMed ID: 30048776
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Locally and systemically active glucocorticosteroids modify intestinal absorption of sugars in rats.
    Thiesen A; Wild GE; Keelan M; Clandinin MT; Thomson AB
    J Appl Physiol (1985); 2003 Feb; 94(2):583-90. PubMed ID: 12391102
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An in vitro comparison of commonly used topical glucocorticoid preparations.
    Stellato C; Atsuta J; Bickel CA; Schleimer RP
    J Allergy Clin Immunol; 1999 Sep; 104(3 Pt 1):623-9. PubMed ID: 10482838
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tobramycin disposition in the rat lung following airway administration.
    Li M; Byron PR
    J Pharmacol Exp Ther; 2013 Nov; 347(2):318-24. PubMed ID: 24008335
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of topical budesonide on epithelial restitution in vivo in guinea pig trachea.
    Erjefält JS; Erjefält I; Sundler F; Persson CG
    Thorax; 1995 Jul; 50(7):785-92. PubMed ID: 7570417
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro/in vivo investigation on the potential of Pluronic® mixed micelles for pulmonary drug delivery.
    Pellosi DS; d'Angelo I; Maiolino S; Mitidieri E; d'Emmanuele di Villa Bianca R; Sorrentino R; Quaglia F; Ungaro F
    Eur J Pharm Biopharm; 2018 Sep; 130():30-38. PubMed ID: 29890256
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metabolic acetal splitting of budesonide. A novel inactivation pathway for topical glucocorticoids.
    Edsbäcker S; Andersson P; Lindberg C; Ryrfeldt A; Thalén A
    Drug Metab Dispos; 1987; 15(3):412-7. PubMed ID: 2886320
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gut mucosal uptake and retention characteristics contribute to the high intestinal selectivity of budesonide compared with prednisolone in the rat.
    Miller-Larsson A; Gustafsson B; Persson CG; Brattsand R
    Aliment Pharmacol Ther; 2001 Dec; 15(12):2019-25. PubMed ID: 11736734
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis of budesonide conjugates and their anti-inflammatory effects: a preliminary study.
    Yan Y; Wang P; Li R; Sun Y; Zhang R; Huo C; Xing J; Dong Y
    Drug Des Devel Ther; 2019; 13():681-694. PubMed ID: 30858698
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulatory effects of aerosolized budesonide and adrenalectomy on the lung content of endothelin-1 in the rat.
    Andersson SE; Eirefelt S; Zackrisson C; Hemsén A; Dahlbäck M; Lundberg JM
    Respiration; 1995; 62(1):34-9. PubMed ID: 7716352
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Topical and oral anti-inflammatory activity of budesonide compared with oral prednisolone in an animal model using allergen-induced gut mucosal exudation of plasma as a marker.
    Gustafsson B; Miller-Larsson A; Persson CG
    Scand J Gastroenterol; 2001 Oct; 36(10):1062-6. PubMed ID: 11589379
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tissue accumulation kinetics of ciclesonide-active metabolite and budesonide in mice.
    Mårs U; d'Argy R; Hallbeck K; Miller-Larsson A; Edsbäcker S
    Basic Clin Pharmacol Toxicol; 2013 Jun; 112(6):401-11. PubMed ID: 23256845
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Developments in anti-asthma glucocorticoids.
    Andersson PT; Persson CG
    Agents Actions Suppl; 1988; 23():239-60. PubMed ID: 3051934
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rapid clearance of xanthines from airway and pulmonary tissues.
    Kröll F; Karlsson JA; Nilsson E; Ryrfeldt A; Persson CG
    Am Rev Respir Dis; 1990 May; 141(5 Pt 1):1167-71. PubMed ID: 2339839
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Decreased retention of fatty acid conjugated DDT metabolites in rats given injections of heparin, bile salts or lecithin.
    Leighty EG
    Res Commun Chem Pathol Pharmacol; 1981 Jan; 31(1):69-76. PubMed ID: 7255875
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of new glucocorticosteroids with a very high ratio between topical and systemic activities.
    Brattsand R; Thalén A; Roempke K; Källström L; Gruvstad E
    Eur J Respir Dis Suppl; 1982; 122():62-73. PubMed ID: 6958495
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antigen-induced bronchial anaphylaxis in actively sensitized SD rats. Effects of glucocorticoid treatment.
    Dahlbäck M; Bergstrand H; Brattsand R
    Allergy; 1986 Apr; 41(3):210-9. PubMed ID: 3087230
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hydrolysis of hydrocortisone 17-butyrate 21-propionate by cultured human keratinocytes.
    Kitano Y
    Acta Derm Venereol; 1986; 66(2):98-102. PubMed ID: 2424252
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhaled budesonide and pulmonary sarcoidosis revisited.
    Selroos O; Brattsand R
    Sarcoidosis Vasc Diffuse Lung Dis; 2024 Sep; 41(3):e2024037. PubMed ID: 39315975
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetic mechanism involved in the prolonged high retention of laninamivir in mouse respiratory tissues after intranasal administration of its prodrug laninamivir octanoate.
    Koyama K; Nakai D; Takahashi M; Nakai N; Kobayashi N; Imai T; Izumi T
    Drug Metab Dispos; 2013 Jan; 41(1):180-7. PubMed ID: 23091189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.